The study explored a new regulatory pathway of FNDC5/irisin in osteoporosis, expanded the research direction of FNDC5/irisin in bone metabolism diseases, and provided a possible new target for type 1 diabetic osteopathy. The gene discussed is FNDC5; the disease is osteoporosis.